Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
filingDate |
1976-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1979-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481d2e0200f92ea7b9c255ce4faebc47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ff0576b39a046448d529bc3978ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48a7d6947eb48b9f52cee431d0645dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d9a2e9033d5f76b83daa60de786b3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5438d66728d315a132cf015ba308b48a |
publicationDate |
1979-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-1063939-A |
titleOfInvention |
Suppression of thrombocyte aggregation |
abstract |
ABSTRACT OF THE DISCLOSURE 2-(4,5-bis-p-chlorophenyloxazol-2-yl-mercapto)-propionic acid and its physiologically acceptable salts in the form of an admixture with acetylsalicylic acid or a physiologically acceptable salt thereof is useful for suppressing aggregation of thrombocytes, particularly when administered in a mole ratio of the acetylsalicylic acid to the priopionic acid derivative of 60:1 to 0.1:1. This is useful especially in humans, e.g. for prophylaxis and therapy in cases involving risk of arterial or venous thrombosis. |
priorityDate |
1975-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |